University of Groningen De Novo Loss-of-Function Mutations in USP 9 X Cause a Female-Specific Recognizable Syndrome with Developmental Delay and Congenital Malformations
暂无分享,去创建一个
R. Pfundt | M. Reijnders | J. Gécz | S. Cheung | H. Brunner | R. Roepman | A. Nordgren | V. Sutton | C. Gilissen | T. Kleefstra | G. Mancini | U. Kini | Z. Stark | S. Wood | B. Anderlid | A. Barnicoat | E. Hobson | H. Malmgren | N. Cooper | S. Price | J. Vogt | L. Jolly | A. Harila-Saari | F. Probst | M. Vreeburg | B. Latour | B. Reversade | P. Magoulas | A. Brooks | Deepti Domingo | J. Lim | A. Lai | H. Veenstra-Knol | Carlo L.M. Marcelis | Kaman Wu | V. Zachariadis | C. Ravenswaaij-Arts | Carlo Marcelis
[1] Alejandro Sifrim,et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data , 2015, The Lancet.
[2] G. Carvill,et al. Seizures Are Regulated by Ubiquitin-specific Peptidase 9 X-linked (USP9X), a De-Ubiquitinase , 2015, PLoS genetics.
[3] J. Gécz,et al. La FAM fatale: USP9X in development and disease , 2015, Cellular and Molecular Life Sciences.
[4] K. Friend,et al. X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes , 2015, Molecular Psychiatry.
[5] Carolyn J. Brown,et al. Landscape of DNA methylation on the X chromosome reflects CpG density, functional chromatin state and X-chromosome inactivation , 2014, Human molecular genetics.
[6] Boris Yamrom,et al. The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.
[7] Carolyn J. Brown,et al. Variable escape from X-chromosome inactivation: Identifying factors that tip the scales towards expression , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.
[8] C. Disteche,et al. X chromosome regulation: diverse patterns in development, tissues and disease , 2014, Nature Reviews Genetics.
[9] S. Rozen,et al. Massively Parallel Sequencing of Patients with Intellectual Disability, Congenital Anomalies and/or Autism Spectrum Disorders with a Targeted Gene Panel , 2014, PloS one.
[10] E. Haan,et al. Mutations in USP9X are associated with X-linked intellectual disability and disrupt neuronal cell migration and growth. , 2014, American journal of human genetics.
[11] Tiziana Franchin,et al. Diagnosis of Noonan syndrome and related disorders using target next generation sequencing , 2014, BMC Medical Genetics.
[12] A. V. Vulto-van Silfhout,et al. Clinical Significance of De Novo and Inherited Copy‐Number Variation , 2013, Human mutation.
[13] D. Horn,et al. A new face of Borjeson–Forssman–Lehmann syndrome? De novo mutations in PHF6 in seven females with a distinct phenotype , 2013, Journal of Medical Genetics.
[14] Claire Redin,et al. XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing. , 2013, American journal of human genetics.
[15] J. Gécz,et al. Loss of Usp9x Disrupts Cortical Architecture, Hippocampal Development and TGFβ-Mediated Axonogenesis , 2013, PloS one.
[16] P. Stankiewicz,et al. Combined array CGH plus SNP genome analyses in a single assay for optimized clinical testing , 2013, European Journal of Human Genetics.
[17] R. Reading,et al. Diagnostic exome sequencing in persons with severe intellectual disability , 2013 .
[18] M. Kirschner,et al. Deubiquitinase FAM/USP9X Interacts with the E3 Ubiquitin Ligase SMURF1 Protein and Protects It from Ligase Activity-dependent Self-degradation , 2012, The Journal of Biological Chemistry.
[19] T. Sixma,et al. The role of UBL domains in ubiquitin-specific proteases. , 2012, Biochemical Society transactions.
[20] R. E. Hughes,et al. Ubiquitin-specific Peptidase 9, X-linked (USP9X) Modulates Activity of Mammalian Target of Rapamycin (mTOR)* , 2012, The Journal of Biological Chemistry.
[21] R. Stevenson,et al. Fragile X and X-linked intellectual disability: four decades of discovery. , 2012, American journal of human genetics.
[22] S. Ware,et al. Spectrum of clinical diseases caused by disorders of primary cilia. , 2011, Proceedings of the American Thoracic Society.
[23] C. Disteche,et al. Genes that escape from X inactivation , 2011, Human Genetics.
[24] Carolyn J. Brown,et al. X-chromosome inactivation: molecular mechanisms from the human perspective , 2011, Human Genetics.
[25] P. Nuciforo,et al. An Atlas of Altered Expression of Deubiquitinating Enzymes in Human Cancer , 2011, PloS one.
[26] M. Shaw,et al. Fine-scale survey of X chromosome copy number variants and indels underlying intellectual disability. , 2010, American journal of human genetics.
[27] Andrew Menzies,et al. A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation , 2009, Nature Genetics.
[28] V. Taylor,et al. USP9X enhances the polarity and self-renewal of embryonic stem cell-derived neural progenitors. , 2009, Molecular biology of the cell.
[29] Leonardo Morsut,et al. FAM/USP9x, a Deubiquitinating Enzyme Essential for TGFβ Signaling, Controls Smad4 Monoubiquitination , 2009, Cell.
[30] B. Franco,et al. Dosage compensation of the mammalian X chromosome influences the phenotypic variability of X-linked dominant male-lethal disorders , 2008, Journal of Medical Genetics.
[31] D. Alessi,et al. Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains. , 2008, The Biochemical journal.
[32] M. Lardelli,et al. Evolutionary and expression analysis of the zebrafish deubiquitylating enzyme, usp9. , 2007, Zebrafish.
[33] P. McPherson,et al. The Ubiquitin Ligase Itch Is Auto-ubiquitylated in Vivo and in Vitro but Is Protected from Degradation by Interacting with the Deubiquitylating Enzyme FAM/USP9X* , 2006, Journal of Biological Chemistry.
[34] Zohreh Talebizadeh,et al. X chromosome gene expression in human tissues: male and female comparisons. , 2006, Genomics.
[35] A. Arnold,et al. Sexually dimorphic expression of Usp9x is related to sex chromosome complement in adult mouse brain , 2005, The European journal of neuroscience.
[36] H. Willard,et al. X-inactivation profile reveals extensive variability in X-linked gene expression in females , 2005, Nature.
[37] J. Chelly,et al. Doublecortin interacts with the ubiquitin protease DFFRX, which associates with microtubules in neuronal processes , 2005, Molecular and Cellular Neuroscience.
[38] S. Wood,et al. The FAM deubiquitylating enzyme localizes to multiple points of protein trafficking in epithelia, where it associates with E-cadherin and beta-catenin. , 2004, Molecular biology of the cell.
[39] S. Brenner,et al. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[40] John S. Mattick,et al. The Ras Target AF-6 is a Substrate of the Fam Deubiquitinating Enzyme , 1998, The Journal of cell biology.
[41] L. Maquat,et al. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. , 1998, Trends in biochemical sciences.
[42] J. Mattick,et al. Cloning and expression analysis of a novel mouse gene with sequence similarity to the Drosophila fat facets gene , 1997, Mechanisms of Development.
[43] M. Jones,et al. The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2. , 1996, Human molecular genetics.
[44] G. Rubin,et al. The fat facets gene is required for Drosophila eye and embryo development. , 1992, Development.
[45] I. Vorobjev,et al. Centrioles in the cell cycle. I. Epithelial cells , 1982, The Journal of cell biology.
[46] A. Pardee,et al. Centriole ciliation is related to quiescence and DNA synthesis in 3T3 cells , 1979, Cell.
[47] K. Kaibuchi,et al. The deubiquitinating enzyme Fam interacts with and stabilizes beta-catenin. , 1999, Genes to cells : devoted to molecular & cellular mechanisms.